SQSTM1 and hepatocellular carcinoma: Conversely, activation of GBA by the specific activator LT1-291 significantly reversed the ability of ART to inhibit HCC cell proliferation and increase the G1 population, LC3B conversion and SQSTM1/p62 accumulation.